Docetaxel

Adding A Platinum Drug to Chemotherapy

Adding A Platinum Drug to Chemotherapy

The study concluded that adding Carboplatin to cabazitaxel showed improved clinical efficacy compared with cabazitaxel alone for men with metastatic castration-resistant prostate cancer. Although adverse events were more common with the combination, the treatment was safe and generally well-tolerated.

A Real-World Analysis Of Outcomes of Early Chemotherapy in Men Newly Diagnosed With Metastatic Prostate Cancer

Recent research has concluded that for men who are going to use early chemotherapy along with hormone therapy, chemotherapy should be delayed, allowing at least three weeks to pass after starting the hormone therapy before commencing the chemotherapy treatments.

A Minimalist Real Time Empirical Look At Chemotherapy

Chemotherapy has a bad reputation because of its side effects.  This reputation has contributed to many men deciding not to use it in their treatment protocol.  Is this a mistake, we present a small amount of empirical evidence that this can be an error.